SB17170
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
SPARK Biopharma
Overview
SB17170 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SB17170 clinical trials
Explore related
Medical disclaimer. This page summarizes research about SB17170 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.